Профиль

Thanks to the entire team! We've already supported many @ishamycology.bsky.social & #ECMM projects with our capacity for multinational collaborative research and we're always happy to support new collaborations. www.nature.com/articles/s41... @salmantongarcia.bsky.social @natcomms.nature.com

Fungal diagnostics and antifungal drug access in Latin America and the Caribbean: an ESCMID EFISG multinational survey - Nature CommunicationsHere, in a survey of 619 institutions across Latin America and the Caribbean, the authors showcase major gaps in fungal diagnostics and antifungal access, with stark disparities linked to income and i...www.nature.com

@salmantongarcia.bsky.social represented our team at the #EHA2026 Congress in Stockholm, connecting with leading experts and exploring the latest developments in hematology. Great conversations, valuable insights, and new perspectives to bring back to our work. #Hematology #Healthcare

New #EFISG Board members 2026-2028 @salmantongarcia.bsky.social – Chair Riina Richardson – Treasurer Dionysios Neofytos– Secretary Claudia Bartalucci– Educational Officer Zoi Dorothea Pana – Scientific Officer @escmid.bsky.social

Viral infections in immunocompromised patients remain an evolving clinical challenge. Key insights from #ESCMID2026 by @salmantongarcia.bsky.social on diagnostics, prophylaxis & antiviral management: touchinfectiousdiseases.com/insight/mana... #InfectiousDiseases #Immunocompromised

New publication in #MedicalMycology: “Profiling medical mycologists” by the #ESCMID #FungalInfection Study Group (#EFISG). Survey of 342 experts from 72 countries highlights the diversity, collaboration, and future needs. @salmantongarcia.bsky.social pubmed.ncbi.nlm.nih.gov/41995303/ #GlobalHealth

Profiling medical mycologists: Results from a global survey of the ESCMID Fungal Infection Study Group (EFISG) - PubMedInvasive fungal infections are a major cause of morbi-mortality, particularly in immunocompromised and critically ill patients. Increasing antifungal resistance, unequal access to diagnostics and ther...pubmed.ncbi.nlm.nih.gov

New accepted manuscript from hashtag #EFISG! 🌍🧫 “Profiling medical mycologists: Results from a global survey of the ESCMID Fungal Infection Study Group” academic.oup.com/mmy/advance-...

Profiling medical mycologists: Results from a global survey of the ESCMID Fungal Infection Study Group (EFISG)Abstract. Invasive fungal infections (IFI) are a major cause of morbi-mortality, particularly in immunocompromised and critically ill patients. Increasingacademic.oup.com

Proud of our team at #ESCMID in Munich! Two great posters today: Luise Hänsel on the 2025 EQUAL Pneumocystis Score & @salmantongarcia.bsky.social Salmanton-García on capacity for invasive fungal diseases in LATAM/Caribbean. Strong results, true team spirit! #Mycology #ID

📢 𝐄𝐅𝐈𝐒𝐆 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐌𝐞𝐞𝐭𝐢𝐧𝐠 🗓 Monday, 20 April 2026 ⏰ 16:15–17:15 CET 📍 ICM 4 (ESCMID Global in Munich) + key4events.zoom.us/j/85290315683?pwd=ydbah1cboY2Z43NtobRMvZ3CEsGuDN.1 🎁 EFISG pins will be available, grab yours!

@salmantongarcia.bsky.social from our team is at the EBMT Annual Meeting 2026 and excited to dive into the latest in cell therapy and transplantation. Looking forward to inspiring talks, new insights, and great conversations! 🚀 👉 Explore the programme: www.ebmt.org/annual-meeti...

Insightful session at EBMT 2026: Dr. Jon Salmanton-García @salmantongarcia.bsky.social presenting on rare fungal infections after HSCT (Fusarium, Scedosporium). Important perspectives on managing complex infections in immunocompromised patients. #EBMT2026 #HSCT #InfectiousDiseases

25 March 2026 at 08:00 CET Candida Endocarditis: when yeast meets the heart uni-koeln.zoom.us/meeting/regi...

🎥 New data on #hMPV in patients with hematologic malignancies: @salmantongarcia.bsky.social highlights how the lack of prophylaxis & treatment increases hospitalizations, ICU needs, and mortality. Watch now: youtu.be/1EsYHcRQZ8g Publication: doi.org/10.1093/ofid... #Hematology #InfectiousDiseases

hMPV in Hematologic Malignancies: Key Insights from EPICOVIDEHA/EPIRESEHAYouTube video by IDIM IDIMyoutu.be

Mycological diagnostics in Australia & NZ vary widely. Key non-culture tests are often offsite, β-D-glucan access is rare, and antifungal resistance surveillance remains limited. Important gaps in regional capability. 🔗 www.sciencedirect.com/science/arti... #Mycology @salmantongarcia.bsky.social

Mycological testing in Australasian clinical mycology laboratories: survey of the current state and access to testingAccess to mycological diagnostics varies across clinical laboratories. This study aimed to assess the availability of key fungal diagnostic methods in…www.sciencedirect.com

🦠 EHA-SWG Infections in Hematology Webinar 📅 March 2, 2026 | 16:00 CET 🎤 @salmantongarcia.bsky.social Insights from the EPIAMLINF registry on infections in AML patients – epidemiology, outcomes & clinical impact. 👉 Register now! ehaweb-org.zoom.us/meeting/regi...

Heute & morgen: Gemeinsame #DZIF/#PEG-Jahrestagung 2026 in Bonn 🦠🔬 Fokus auf Gender & Precision Medicine, AMR, Drug Development & Wirt-Erreger-Interaktionen. Unser Team ist heute mit 3 Postern vertreten @salmantongarcia.bsky.social! 💬🖼️ #InfectiousDiseases #AMR #Science

Info for registered EFISG members: Voting for EFISG Board ('26–'28) is open until March 2nd To vote: Log in at my.escmid.org 🖱️“Study group elections” 🖱️“ESCMID Fungal Infection Study Group (EFISG) [Election open]” 🖱️“Vote ballot” 🖱️Candidate(s) and click “VOTE”

At PRISMA Congress, @salmantongarcia.bsky.social presents "The evolving challenge of fungal resistance", highlighting the latest developments and emerging clinical challenges in antifungal resistance. #PRISMA2026 #FungalResistance

Join the EFISG webinar “Women in Science – Past, Present, and Future” 🧬 📅 11 Feb 2026 | 🕕 18:00 CET 🎓 Inspiring speakers & discussions on women’s careers in science. 👉 Register: us06web.zoom.us/webinar/regi... @salmantongarcia.bsky.social #EFISG_FREE_WEBINAR

#EFISG webinars January - April 2026 More info: www.escmid.org/efisg @escmid.bsky.social @taescmid.bsky.social

Nomination phase for EFISG Board ('26–'28) open from 06-01 to 02-02. Each candidate requires support from two EFISG members. To nominate: my.escmid.org → SG elections → EFISG → Support members Good luck to all candidates!